“El Periódico de Catalunya” has published an article about a new technique, called Crispr/Cas9, to modify the genome. This method is innovative because it allows modifications to be made in a more straightforward and faster manner than with previously used approaches. The article includes statements made by researchers specialized in the field of genomics, including Stephen Forrow, head of the “Mouse Mutant Core Facility” at IRB Barcelona.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to offer pioneering solutions to unresolved medical needs in cancer and other diseases related to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).